Evidence map›Paper›PMID 33237744›Full record

ArticleAnalytical chemistry2020

Nanomolar Protein-Protein Interaction Monitoring with a Label-Free Protein-Probe Technique.

Salla Valtonen, Emmiliisa Vuorinen, Taru Kariniemi, Ville Eskonen, John Le Quesne, Martin Bushell, Harri Härmä, Kari Kopra

Open access · hybridAbstract read
In one paragraph

Article in Analytical chemistry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.3field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Fluorescence-Based Protein Stability Monitoring-A Review.International journal of molecular sciences · 2024
    Review
  4. Luminescence-Based Techniques for KRAS Thermal Stability Monitoring.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Salla ValtonenDepartment of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.ORCID 0000-0002-4948-7169
Emmiliisa VuorinenDepartment of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.
Taru KariniemiDepartment of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.
Ville EskonenDepartment of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.ORCID 0000-0001-5214-5904
John Le QuesneUniversity of Cambridge, MRC Toxicology Unit, Hodgkin Building, Lancaster Road, Leicester LE1 7HB, U.K.
Martin BushellCancer Research U.K. Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, U.K.
Harri HärmäDepartment of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.ORCID 0000-0002-8936-039X
Kari KopraDepartment of Chemistry, Chemistry of Drug Development, University of Turku, Vatselankatu 2, 20500 Turku, Finland.ORCID 0000-0001-7585-6020
University of Turku · FICancer Research UK Scotland Institute · GBUniversity of Leicester · GB

Funding

Cancer Research UK 24388Cancer Research UK 29252Medical Research Council MC_UP_A600_1024
6 · The paper itself

Abstract

Protein-protein interactions (PPIs) are an essential part of correct cellular functionality, making them increasingly interesting drug targets. While Förster resonance energy transfer-based methods have traditionally been widely used for PPI studies, label-free techniques have recently drawn significant attention. These methods are ideal for studying PPIs, most importantly as there is no need for labeling of either interaction partner, reducing potential interferences and overall costs. Already, several different label-free methods are available, such as differential scanning calorimetry and surface plasmon resonance, but these biophysical methods suffer from low to medium throughput, which reduces suitability for high-throughput screening (HTS) of PPI inhibitors. Differential scanning fluorimetry, utilizing external fluorescent probes, is an HTS compatible technique, but high protein concentration is needed for experiments. To improve the current concepts, we have developed a method based on time-resolved luminescence, enabling PPI monitoring even at low nanomolar protein concentrations. This method, called the protein probe technique, is based on a peptide conjugated with Eu

Indexed as

CalorimetryChelating AgentsEukaryotic Initiation Factor-4AEuropiumFluorescence Resonance Energy TransferHumansPeptidesProtein BindingProtein ConformationProto-Oncogene Proteins p21(ras)Surface Plasmon ResonanceChelating AgentsEIF4A1 protein, humanEukaryotic Initiation Factor-4AEuropiumKRAS protein, humanPeptidesProto-Oncogene Proteins p21(ras)

Identifiers

PMID33237744
PMCPMC7745204
OpenAlexW3110600119

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.